Company News in the Life Science Industry

»

Reset 

NGM Bio Appoints Hsiao D. Lieu, M.D. as SVP, Chief Medical Officer and Alex DePaoli, M.D. to New Role of SVP, Chief Translational Officer

SOUTH SAN FRANCISCO, Calif., March 20, 2019 /PRNewswire/ -- NGM Biopharmaceuticals, Inc., a clinical stage biotechnology company focused on harnessing powerful biology underlying major diseases to develop transformative therapeutics for patients, today announced the appointment of Hsiao D. Lieu,... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  NGM Biopharmaceuticals, Inc.

GreenMark Secures Additional Funding for Cavity Identification and Treatment

EAST LANSING, Mich. and ANN ARBOR, Mich., March 20, 2019 /PRNewswire/ -- GreenMark Biomedical Inc. today announced it secured $670,000 equity funding, completing a $1.2 million Series Seed Preferred Stock round to further develop and commercialize its patented nanoparticle-based dental... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019

Canopy Growth announces multi-year extraction agreement with Victoria-based HollyWeed North Cannabis Inc.

SMITHS FALLS, ON and VICTORIA, BC, March 20, 2019 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or the "Company") and HollyWeed Manufacturing & Extracts Inc. are pleased to announce today they have entered into a multi-year processing and extraction agreement.... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019

2018 financial results and business update: landmark deal with AstraZeneca to support transition into a fully integrated oncology-focused biotech, strong clinical progress in lead assets

Read more ››
By: Nasdaq / GlobenewsWire - 20 Mar 2019
Related companies:  Innate Pharma S.A.

CalciMedica, Inc. to Present Study Population Profile from its Initial Patient Study of its CRAC Channel Inhibitor CM4620 in Acute Pancreatitis at International Conference

LA JOLLA, Calif., March 19, 2019 /PRNewswire/ -- Physicians from several study sites involved in CalciMedica's initial acute pancreatitis clinical study of its CRAC channel inhibitor CM4620 (NCT03401109) and CalciMedica, Inc., presented a poster today at the 39(th) International Symposium on... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  CalciMedica, Inc

resTORbio, Inc. Announces Pricing of Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 20 Mar 2019
Related companies:  resTORbio, Inc.

Dermira Prices $130.0 Million Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 20 Mar 2019
Related companies:  Dermira Inc.

WuXi Biologics Receives EMA GMP Certificates

SHANGHAI and WUXI, China, March 19, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has received EMA GMP certificates... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  WuXi Biologics

Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer

DARMSTADT, Germany and NEW YORK, March 19, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2019
Related companies:  Pfizer Inc.

UK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Says

GENEVA, March 20, 2019 /PRNewswire/ -- Today on World Oral Health Day (WOHD), FDI World Dental Federation (FDI) released the results of a survey from 13 countries, which asked parents with children aged 5-16 if their child's school provided lessons on good oral care. Poor oral health can negatively... Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019

The Latin America pharmaceutical excipients market is projected to reach USD 579 million by 2024 from USD 403 million in 2019, at a CAGR of 7.5%

NEW YORK, March 19, 2019 /PRNewswire/ -- The LATAM pharmaceutical excipients market is projected to grow at a CAGR of 7.5% during the forecast period (2019-2024).

Read the full report: Read more ››

By: PR Newswire Association LLC. - 20 Mar 2019

Principia Biopharma Reports Fourth Quarter and Full Year 2018 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019
Related companies:  Principia BioPharma, Inc.

Rubius Therapeutics to Announce Fourth Quarter and Full-Year 2018 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019
Related companies:  Rubius Therapeutics Inc.

DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019

Oasmia Pharmaceutical AB (publ): Press release from the extraordinary general meeting 19 March 2019

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019
Related companies:  Oasmia Pharmaceutical AB

Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019

I-Mab Biopharma and MorphoSys Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma

SHANGHAI, March 19, 2019 /PRNewswire/ -- I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune diseases, and German biopharma company MorphoSys AG (FSE: MOR; Prime Standard... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019
Related companies:  Jiangsu T-mab BioPharma | I-Mab Biopharma

Cure SMA and Parent Project Muscular Dystrophy Announce Strategic Collaboration with Prometheus Research

CHICAGO, March 19, 2019 /PRNewswire/ -- Today, Cure SMA and Parent Project Muscular Dystrophy (PPMD), two of the world's leading rare disease patient advocacy organizations, announced... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019
Related companies:  CURE SMA | Prometheus Research, LLC

FDA issues warning letters to two breast implant manufacturers for failure to comply with post-approval study requirements

SILVER SPRING, Md., March 19, 2019 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued warning letters to two breast implant manufacturers for failure to comply with their requirements, under their premarket approval orders, to conduct post-approval studies to assess the long-term... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019
Related companies:  U.S. Food and Drug Administration

Northpoint Recovery Announces John Flanagan as CEO

BOISE, Idaho, March 19, 2019 /PRNewswire/ -- Northpoint Recovery, which operates inpatient and outpatient addiction treatment facilities in Idaho and Washington, has named John Flanagan, a 30-year veteran of the behavioral health industry, as Chief Executive Officer.

Read more ››
By: PR Newswire Association LLC. - 19 Mar 2019
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies